Carmell Therapeutics Stock Probability of Future Stock Price Finishing Under 0.051
| CTCXW Stock | 0.02 0.03 60.24% |
Carmell |
Carmell Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Carmell Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Carmell Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Carmell Therapeutics generated a negative expected return over the last 90 days | |
| Carmell Therapeutics has high historical volatility and very poor performance | |
| Carmell Therapeutics has some characteristics of a very speculative penny stock | |
| Carmell Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (15.45 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Carmell Therapeutics generates negative cash flow from operations | |
| Carmell Therapeutics has a frail financial position based on the latest SEC disclosures |
Carmell Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Carmell Stock often depends not only on the future outlook of the current and potential Carmell Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Carmell Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 11 M | |
| Cash And Short Term Investments | 2.9 M |
Carmell Therapeutics Technical Analysis
Carmell Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Carmell Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Carmell Therapeutics. In general, you should focus on analyzing Carmell Stock price patterns and their correlations with different microeconomic environments and drivers.
Carmell Therapeutics Predictive Forecast Models
Carmell Therapeutics' time-series forecasting models is one of many Carmell Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Carmell Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Carmell Therapeutics
Checking the ongoing alerts about Carmell Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Carmell Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Carmell Therapeutics generated a negative expected return over the last 90 days | |
| Carmell Therapeutics has high historical volatility and very poor performance | |
| Carmell Therapeutics has some characteristics of a very speculative penny stock | |
| Carmell Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (15.45 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Carmell Therapeutics generates negative cash flow from operations | |
| Carmell Therapeutics has a frail financial position based on the latest SEC disclosures |
Additional Tools for Carmell Stock Analysis
When running Carmell Therapeutics' price analysis, check to measure Carmell Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Carmell Therapeutics is operating at the current time. Most of Carmell Therapeutics' value examination focuses on studying past and present price action to predict the probability of Carmell Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Carmell Therapeutics' price. Additionally, you may evaluate how the addition of Carmell Therapeutics to your portfolios can decrease your overall portfolio volatility.